↓ Skip to main content

The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors

Overview of attention for article published in Journal for Immunotherapy of Cancer, October 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
5 news outlets
blogs
1 blog
twitter
24 tweeters
patent
2 patents

Citations

dimensions_citation
445 Dimensions

Readers on

mendeley
350 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors
Published in
Journal for Immunotherapy of Cancer, October 2019
DOI 10.1186/s40425-019-0768-9
Pubmed ID
Authors

Andrew A. Davis, Vaibhav G. Patel

Twitter Demographics

The data shown below were collected from the profiles of 24 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 350 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 350 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 50 14%
Student > Ph. D. Student 49 14%
Researcher 47 13%
Student > Bachelor 36 10%
Other 21 6%
Other 55 16%
Unknown 92 26%
Readers by discipline Count As %
Medicine and Dentistry 85 24%
Biochemistry, Genetics and Molecular Biology 62 18%
Immunology and Microbiology 21 6%
Agricultural and Biological Sciences 19 5%
Pharmacology, Toxicology and Pharmaceutical Science 17 5%
Other 47 13%
Unknown 99 28%

Attention Score in Context

This research output has an Altmetric Attention Score of 54. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 September 2022.
All research outputs
#660,088
of 22,663,969 outputs
Outputs from Journal for Immunotherapy of Cancer
#162
of 2,884 outputs
Outputs of similar age
#16,257
of 360,446 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#4
of 98 outputs
Altmetric has tracked 22,663,969 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,884 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.5. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 360,446 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 98 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.